By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – SDIX today reported that its fourth-quarter revenues dipped 13 percent year over year, as its Life Science business dropped 11 percent.

For the period ended Dec. 31, 2011, total revenues were $5.5 million, down from $6.3 million a year ago. Life Science brought in revenues of $3.8 million, compared to $4.2 million in Q4 2010, a drop that the company attributed to order timing in the IVD business as larger orders were placed earlier during 2011.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: self-assembly of DNA components in solution, and more.

Genetics and Molecular Research retracts two gastric cancer papers for being "substantially equal" to other papers, according to Retraction Watch.

A new analysis indicates that the Ebola virus behind the current West African outbreak is mutating at about the same rate as other Ebola viruses.

With the launch of Scott Kelly into space today, the study of him and his earthbound brother to disentangle the effects of life in space from the effects of genetics kicks off.